Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Mintz

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
The Laryngoscope|February 24, 2001
Autologous fibrin sealant reduces pain after tonsillectomyC W Gross, R Gallagher, R J Schlosser, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Clotting Factor (Cf) Product Use And Same-Day Risk For Thrombotic Adverse Events (Tes), As Recorded In Large Health Care Database During 2008-2013 Study PeriodB F Ekezue, G Sridhar, H S Izurieta, et al.
Vox Sanguinis|December 4, 2014
Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012M Menis, R A Forshee, S A Anderson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2015
Clotting factor product administration and same-day occurrence of thrombotic events, as recorded in a large healthcare database during 2008-2013B F Ekezue, G Sridhar, M V Ovanesov, et al.
Transfusion|September 16, 2000
MAM: a "new" high-incidence antigen found on multiple cell linesW M Montgomery, S J Nance, S F Donnelly, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
The Laryngoscope|February 24, 2001
Autologous fibrin sealant reduces pain after tonsillectomyC W Gross, R Gallagher, R J Schlosser, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Clotting Factor (Cf) Product Use And Same-Day Risk For Thrombotic Adverse Events (Tes), As Recorded In Large Health Care Database During 2008-2013 Study PeriodB F Ekezue, G Sridhar, H S Izurieta, et al.
Vox Sanguinis|December 4, 2014
Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012M Menis, R A Forshee, S A Anderson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2015
Clotting factor product administration and same-day occurrence of thrombotic events, as recorded in a large healthcare database during 2008-2013B F Ekezue, G Sridhar, M V Ovanesov, et al.
Transfusion|September 16, 2000
MAM: a "new" high-incidence antigen found on multiple cell linesW M Montgomery, S J Nance, S F Donnelly, et al.
Pageof 9